Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Intuitive Surgical Earnings Preview: What to Expect

December 23, 2025 at 04:46 AM EST

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

With a market cap of $205.2 billion, Intuitive Surgical, Inc. (ISRG) is a prominent technology and medical device company that is widely regarded as the global leader in robotic-assisted, minimally invasive surgery. Its headquarters are in Sunnyvale, California, and its flagship offerings include the da Vinci Surgical System and the Ion endoluminal system, supported by a comprehensive portfolio of instruments, accessories, services, and digital solutions.

The med-tech titan is expected to announce its fiscal Q4 2025 results soon. Ahead of this event, analysts expect Intuitive Surgical to report an EPS of $1.83, down 5.2% from $1.93 in the year-ago quarter. It has exceeded Wall Street's earnings estimates in the last four quarters.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

For fiscal 2025, analysts predict the company to report an EPS of $6.93, a 6.9% rise from $6.48 in fiscal 2024. Moreover, EPS is anticipated to grow 12.4% year over year to $7.79 in fiscal 2026.

Shares of Intuitive Surgical have surged 10.6% over the past 52 weeks, lagging behind the S&P 500 Index's ($SPX) 16% gain and the Health Care Select Sector SPDR Fund’s (XLV) 12.5% return over the same period.

On Dec. 11, shares of Intuitive Surgical fell more than 1% after Citigroup Inc. (C) downgraded the stock to “Neutral” from “Buy,” signaling a more cautious near-term outlook despite the company’s strong fundamentals.

Analysts' consensus view on ISRG stock is cautiously optimistic, with an overall "Moderate Buy" rating. Among 29 analysts covering the stock, 18 suggest a "Strong Buy," two give a "Moderate Buy," eight recommend a "Hold," and one has a "Strong Sell." The average analyst price target for Intuitive Surgical is $614.04, implying a 5.9% upside from current price levels.

On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article